Attached files
| file | filename |
|---|---|
| S-1/A - FORM S-1/A - Kintara Therapeutics, Inc. | fs12015a9_delmarpharma.htm |
| EX-10.19 - U.S. SUBSCRIPTION AGREEMENT - Kintara Therapeutics, Inc. | fs12015a9ex10xix_delmarpharm.htm |
| EX-4.1 - FORM OF WARRANT - Kintara Therapeutics, Inc. | fs12015a9ex4i_delmarpharma.htm |
| EX-10.20 - CANADIAN SUBSCRIPTION AGREEMENT - Kintara Therapeutics, Inc. | fs12015a9ex10xx_delmarpharma.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the inclusion in this registration statement on the Form S-1/A Amendment No.9 of
DelMar Pharmaceuticals, Inc. of our report dated August 28, 2014 relating to the financial statements of
DelMar Pharmaceuticals, Inc., which appears in the Form S-1/A Amendment No.9. We also consent to the
references to us under the heading “Experts” in such registration statement.
(signed) PricewaterhouseCoopers LLP
Chartered Accountants
Vancouver, British Columbia
July 9, 2015